Supernus Pharmaceuticals, Inc. (FRA:S49)
Germany · Delayed Price · Currency is EUR 41.20
+0.60 (1.48%)
At close: Jan 27, 2026
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of €2.32 billion as of January 30, 2026. Its market cap has increased by 13.05% in one year.
Market Cap
2.32B
Enterprise Value
2.12B
Revenue
580.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
€41.20
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from 97.10M to 2.32B, an increase of 2,293.83%. That is a compound annual growth rate of 25.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 2.32B | -4.24% |
| Dec 31, 2025 | 2.43B | 25.85% |
| Dec 31, 2024 | 1.93B | 34.83% |
| Dec 29, 2023 | 1.43B | -20.72% |
| Dec 30, 2022 | 1.80B | 32.32% |
| Dec 31, 2021 | 1.36B | 25.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lechwerke AG | 2.48B |
| Mainova AG | 2.45B |
| Tradegate AG Wertpapierhandelsbank | 2.10B |
| Gelsenwasser AG | 1.80B |
| tonies SE | 1.19B |
| Sedlmayr Grund und Immobilien AG | 932.55M |
| Berliner Effektengesellschaft AG | 879.96M |
| Northern Data AG | 842.90M |